MeSH Browser

MeSH Supplementary: ALL-82 protocol
Unique ID: C471581
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C471581
Registry Number: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Methotrexate; Teniposide; Mercaptopurine / *analogs & derivatives
Frequency: 1
Note: chemotherapy protocol consisting of methotrexate, VM-26, doxorubicin, cytarabine, 6-methylmercaptopurine, and CTX for the treatment of acute lymphoid leukemia
Source: Leuk Res 2003 Jan;27(1):45-50
Date of Entry: 2003/03/01
Revision Date: 2013/11/06

ALL-82 protocol MeSH Supplementary Concept Data 2024